Hepatic encephalopathy
Also known as: Hepatic encephalopathy (HE), Portosystemic encephalopathy, Hepatic coma (severe manifestation)
Hepatic encephalopathy (HE) is brain dysfunction associated with liver insufficiency or portosystemic shunting, ranging from subtle cognitive impairment to confusion and coma. The clinical priority remains urgent medical evaluation, identification of precipitating factors, and standard hepatology-directed management. the cited evidence describes neuroimaging associations rather than therapeutic efficacy or validated biomarkers. Supplemental records regarding IBS or acupuncture for unrelated cognitive disorders do not establish benefit for HE. Acupuncture and Chinese herbal medicine (CHM) have no demonstrated HE benefit in this cited evidence base. Traditional patterns serve only as conceptual frameworks for medically stable patients; they do not address hyperammonaemia and must never substitute for specialist hepatology care. CHM usage requires review for hepatotoxicity and medication safety.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Maintain strict adherence to prescribed pharmacological regimens and achieve directed bowel-frequency targets; do not modify laxative therapies or substitute them with herbal preparations.
- •Consult a specialist hepatology dietitian to maintain optimal nutritional status; avoid fasting or unadvised protein restriction.
- •Maintain total abstinence from alcohol and consult the treating clinical team before using any over-the-counter medications, sedatives, or supplements.
- •Engage caregiver support for medication management and monitoring of cognitive status; refrain from driving or operating heavy machinery until formal medical clearance is obtained.
Cautions & Contraindications
- •Do not provide elective acupuncture or oral herbal treatment during suspected active HE, impaired decision-making or unsafe swallowing; arrange medical assessment. Sources [1–2] describe HE-associated brain abnormalities but do not test this procedural precaution.[,]
- •Defer needling pending medical review when there is active bleeding, clinically significant coagulopathy, severe thrombocytopenia, infection or unstable decompensation. Avoid infected skin, marked oedema and abdominal needling over ascites. These are general clinical precautions, not findings of the supplied HE studies.[,]
- •Do not infer HE efficacy or safety from the aMCI acupuncture protocol: it reports no treatment outcomes and concerns a different condition. Likewise, IBS recommendations cannot justify HE treatment or medication substitution.[,]
- •The supplied imaging studies establish no herbal efficacy, hepatic safety or interaction profile. Require hepatology and pharmacy review before any formula; do not introduce herbs during acute deterioration or use them to replace prescribed HE treatment.[,]
When to reassess or seek care again
If medically cleared adjunctive care is undertaken, establish baseline alertness, caregiver-reported function, appetite, sleep and prescribed stool-target adherence. Check mental status before every visit and review comfort and adverse effects within 1–2 weeks; stop if there is no meaningful symptomatic benefit. Any new confusion, reduced alertness, bleeding, fever or decline in function requires immediate medical reassessment rather than waiting for the review. Clinical recovery cannot be inferred from ammonia or research MRI measures alone.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Brain research bulletin · 2026
- Frontiers in neurology · 2026
- Journal of clinical gastroenterology · 2026
- PloS one · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
